Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation

J L Cmarik1, H Min, G Hegamyer

  • 1Basic Research Laboratory, Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, MD 21702, USA. cmarik@ncifcrf.gov

Insights

The Pdcd4 protein inhibits neoplastic transformation by preventing tumor promoter-induced changes in cells. Reduced Pdcd4 levels lead to a transformation-sensitive phenotype, while its overexpression restores resistance.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell biology

Background:

  • JB6 cells are mouse epidermal cells used to study neoplastic transformation.
  • Promotion-sensitive (P+) cells transform in response to tumor promoters, unlike promotion-resistant (P-) cells.

Purpose of the Study:

  • To identify novel genes involved in inhibiting neoplastic transformation.
  • To investigate the function of the Pdcd4 gene product in cellular transformation.

Main Methods:

  • Differential display screening of mouse JB6 P+ and P- cells.
  • cDNA isolation and sequencing of a differentially expressed gene fragment (A7-1).
  • Generation of stable cell lines expressing antisense Pdcd4 and sense Pdcd4 fragments.

Main Results:

  • A novel gene product, Pdcd4 (Programmed Cell Death 4), was identified and found to be highly expressed in P- cells.
  • Pdcd4 protein levels correlated with mRNA expression, being higher in P- cells.
  • Reducing Pdcd4 levels in P- cells induced a P+ phenotype, while restoring Pdcd4 expression reverted cells to a P- phenotype.

Conclusions:

  • The Pdcd4 protein functions as a critical inhibitor of neoplastic transformation.
  • Pdcd4 plays a significant role in determining cellular sensitivity or resistance to tumor promoters.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...